U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT06929182) titled 'OBServaToIre interNational Des Patients AnTiphospholipidEs traites Par Anticoagulants Oraux Directs' on April 08.
Brief Summary: This registry will make it possible to collect large-scale data on SAPL patients, particularly those treated with DOACs, in order to better assess the frequency of thrombotic and hemorrhagic events in this population of "non-high-risk" thrombotic SAPL patients treated with DOACs. The results will help refine treatment recommendations and could form the basis of future clinical trials.
In this study, there will be no modification of the usual care and no additional follow-up. Follow-up will be carried out...